<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Despite appropriate treatment, surgery for <z:hpo ids='HP_0002647'>aortic dissection</z:hpo> is frequently associated with <z:mp ids='MP_0001914'>bleeding</z:mp> problems </plain></SENT>
<SENT sid="1" pm="."><plain>In these series we report on the employment of recombinant activated factor VII (rFVIIa) for refractory <z:mp ids='MP_0001914'>hemorrhage</z:mp> after emergency surgery for <z:hpo ids='HP_0011009'>acute</z:hpo> type A <z:hpo ids='HP_0002647'>aortic dissection</z:hpo>, used to face the problems of postoperative blood loss and transfusion requirements </plain></SENT>
<SENT sid="2" pm="."><plain>Despite the good results of the therapy, a patient presented with <z:mp ids='MP_0005048'>thrombosis</z:mp> of the left cavernous sinus </plain></SENT>
<SENT sid="3" pm="."><plain>Although a risk of thromboembolic complications has to be considered, rFVIIa is a reasonable rescue option in life-threatening <z:mp ids='MP_0001914'>hemorrhage</z:mp> and enlarges our hemostatic armamentarium in surgery for <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0002647'>aortic dissection</z:hpo> </plain></SENT>
</text></document>